ZA201001066B - Novel forms of CDDO methyl ester - Google Patents

Novel forms of CDDO methyl ester

Info

Publication number: ZA201001066B
Authority: ZA; South Africa
Prior art keywords: methyl ester; novel forms; cddo methyl; cddo; novel
Prior art date: 2007-08-15

Application number

ZA201001066A

Other languages

English (en)

Inventor

John Walling

Stephan D Parent

David T Jonaitis

Robert M Kral

Original Assignee

Reata Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-15

Filing date

2010-02-12

Publication date

2010-10-27

2010-02-12 Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc

2010-10-27 Publication of ZA201001066B publication Critical patent/ZA201001066B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Glass Compositions (AREA)

ZA201001066A 2007-08-15 2010-02-12 Novel forms of CDDO methyl ester ZA201001066B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US95593907P	2007-08-15	2007-08-15

Publications (1)

Publication Number	Publication Date
ZA201001066B true ZA201001066B (en)	2010-10-27

Family

ID=40351005

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA201001066A ZA201001066B (en)	2007-08-15	2010-02-12	Novel forms of CDDO methyl ester

Country Status (28)

Country	Link
US (3)	US8088824B2 (xx)
EP (2)	EP2187741B1 (xx)
JP (4)	JP5005812B2 (xx)
KR (2)	KR101481764B1 (xx)
CN (2)	CN101820758B (xx)
AR (2)	AR073155A1 (xx)
AT (1)	ATE549035T1 (xx)
AU (1)	AU2008287388B2 (xx)
BR (1)	BRPI0815540A8 (xx)
CA (2)	CA2871864C (xx)
CL (1)	CL2008002417A1 (xx)
CY (2)	CY1112864T1 (xx)
DK (2)	DK2450057T3 (xx)
EA (2)	EA018704B1 (xx)
ES (2)	ES2602978T3 (xx)
HR (2)	HRP20120350T1 (xx)
HU (1)	HUE031866T2 (xx)
IL (2)	IL203824A (xx)
LT (1)	LT2450057T (xx)
MX (1)	MX2010001628A (xx)
NZ (1)	NZ583269A (xx)
PL (2)	PL2187741T3 (xx)
PT (2)	PT2450057T (xx)
SG (2)	SG177905A1 (xx)
SI (2)	SI2187741T1 (xx)
TW (2)	TWI486357B (xx)
WO (1)	WO2009023232A1 (xx)
ZA (1)	ZA201001066B (xx)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6326507B1 (en) *	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
US7435755B2 (en)	2000-11-28	2008-10-14	The Trustees Of Dartmouth College	CDDO-compounds and combination therapies thereof
US7176237B2 (en)	2002-01-15	2007-02-13	The Trustees Of Dartmouth College	Tricyclic-bis-enone derivatives and methods of use thereof
US8921340B2 (en)	2006-11-17	2014-12-30	Trustees Of Dartmouth College	Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
WO2008064132A2 (en)	2006-11-17	2008-05-29	Trustees Of Dartmouth College	Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
US7714012B2 (en)	2006-11-17	2010-05-11	Trustees Of Dartmouth University	Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
US8088824B2 (en) *	2007-08-15	2012-01-03	Reata Pharmaceuticals Inc.	Forms of CDDO methyl ester
LT2252283T (lt) *	2008-01-11	2019-03-25	Reata Pharmaceuticals, Inc.	Sintetiniai triterpenoidai ir jų panaudojimo būdai gydant ligą
WO2009129545A1 (en)	2008-04-18	2009-10-22	Reata Pharmaceuticals, Inc.	Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
WO2009146216A2 (en)	2008-04-18	2009-12-03	Reata Pharmaceuticals. Inc.	Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721665C (en)	2008-04-18	2017-01-24	Reata Pharmaceuticals, Inc.	Compounds including an anti-inflammatory pharmacore and methods of use
KR101735807B1 (ko)	2008-04-18	2017-05-15	리타 파마슈티컬스 잉크.	Ｃ-17에 아미노 및 기타 변형을 갖는 올레아놀산 유도체를 포함하는 항산화 염증 조절제
HUE033288T2 (en)	2008-04-18	2017-11-28	Reata Pharmaceuticals Inc	Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
AU2009274037B2 (en)	2008-07-22	2015-07-09	Trustees Of Dartmouth College	Monocyclic cyanoenones and methods of use thereof
ES2646816T3 (es) *	2009-02-13	2017-12-18	Reata Pharmaceuticals, Inc.	Composiciones de dosificaciones orales de liberación retardada que contienen CDDO-Me amorfo
US8759535B2 (en)	2010-02-18	2014-06-24	High Point Pharmaceuticals, Llc	Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
MY163031A (en)	2010-04-12	2017-07-31	Reata Pharmaceuticals Inc	Method of treating obesity using antioxidant inflammation modulators
HUE038046T2 (hu)	2010-12-17	2018-09-28	Reata Pharmaceuticals Inc	Antioxidáns gyulladáscsökkentõ pirazolil és pirimidinil triciklusos enonok
MX339243B (es)	2011-02-03	2016-05-18	Vtv Therapeutics Llc	Derivados fusionados sustituidos de imidazol, composiciones farmaceuticas y metodos de uso de los mismos.
CN103619866B (zh)	2011-03-11	2016-06-22	里亚塔医药公司	C4-一甲基三萜系化合物的衍生物及其使用方法
CN103156861B (zh) *	2011-12-08	2015-11-25	陈丽梅	齐敦果酸衍生物及其可药用盐在治疗糖尿病眼病中的应用
ME02926B (me) *	2012-04-27	2018-04-20	Reata Pharmaceuticals Inc	2,2-difluoropropionamidni derivati bardoksolon metila, polimorfni oblici i postupci za njihovu upotrebu
US8921419B2 (en)	2012-05-08	2014-12-30	Trustees Of Dartmouth College	Triterpenoids and compositions containing the same
US8981144B2 (en)	2012-05-08	2015-03-17	Trustees Of Dartmouth College	Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof
US9556222B2 (en)	2012-06-15	2017-01-31	Reata Pharmaceuticals, Inc.	A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
US9512094B2 (en)	2012-09-10	2016-12-06	Reata Pharmaceuticals, Inc.	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US20140073700A1 (en) *	2012-09-10	2014-03-13	Abbvie Inc.	Glycyrrhetinic acid derivatives and methods of use thereof
CR20150117A (es)	2012-09-10	2016-10-10	Reata Pharmaceuticals Inc	Derivados c17-alcandilo y alquendilo del ácido oleanólico y sus métodos de uso
US9278912B2 (en)	2012-09-10	2016-03-08	Reata Pharmaceuticals, Inc.	C13-hydroxy derivatives of oleanolic acid and methods of use thereof
JP5972986B2 (ja)	2012-09-28	2016-08-17	アプライドファーマシューティカルサイエンスインコーポレイテッド	Ｃｄｄｏエチルエステルの多形体及びその用途
CN102887936A (zh) *	2012-10-24	2013-01-23	苏州晶云药物科技有限公司	2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯晶型
CN102875634B (zh) *	2012-10-24	2014-08-20	苏州晶云药物科技有限公司	2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的几种晶型
TW201514192A (zh)	2013-03-19	2015-04-16	Daiichi Sankyo Co Ltd	萜類衍生物
UY39092A (es)	2013-04-24	2021-03-26	Abbvie Inc	Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
US20150080465A1 (en) *	2013-08-23	2015-03-19	Reata Pharmaceuticals, Inc.	Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
WO2016033132A1 (en)	2014-08-26	2016-03-03	Trustees Of Dartmouth College	Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
US10189791B2 (en)	2014-08-26	2019-01-29	Trustees Of Dartmouth College	Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
EP3192875B1 (en)	2014-09-10	2019-12-18	Daiichi Sankyo Company, Limited	Sustained-release pharmaceutical composition for treating and preventing ophthalmic diseases
WO2016089648A1 (en)	2014-12-01	2016-06-09	Vtv Therapeutics Llc	Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
US11591302B2 (en)	2014-12-19	2023-02-28	Geistlich Pharm A Ag	Processes for preparing oxathiazin-like compounds
CN107257786B (zh)	2014-12-19	2019-12-24	盖斯特里希医药公司	制备噁噻嗪样化合物的方法
US11059792B2 (en)	2015-02-12	2021-07-13	Reata Pharmaceuticals, Inc.	Imidazolyl tricyclic enones as antioxidant inflammation modulators
SI3317281T1 (sl) *	2015-07-02	2020-08-31	Acerta Pharma B.V.	Trdne oblike in formulacije (s)-4-(8-amino-3-(1-(but-2-inoil)pirolidin -2-il)imidazo(1,5-a)pirazin-1-il)-n-(piridin-2-il)benzamida
EA201890767A1 (ru)	2015-09-23	2019-09-30	Рита Фармасьютикалз, Инк.	C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений
MA46749A (fr)	2016-11-08	2019-09-18	Reata Pharmaceuticals Inc	Méthodes de traitement du syndrome d'alport à l'aide d'un méthyle de bardoxolone ou d'analogues de ce dernier
TWI831738B (zh)	2016-12-16	2024-02-11	美商瑞塔醫藥有限責任公司	用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
WO2019014412A1 (en)	2017-07-13	2019-01-17	Pliva Hrvatska D.O.O.	NOVEL CRYSTALLINE POLYMORPHIC FORMS OF METHYL BARDOXOLONE
JP7244536B2 (ja)	2018-04-06	2023-03-22	キャプシュゲル・ベルジウム・エヌ・ヴィ	メタクリル酸メチル－メタクリル酸コポリマーからなる低アスペクト比の粒子のための噴霧乾燥方法
BR112020025605A2 (pt)	2018-06-15	2021-03-23	Reata Pharmaceuticals, Inc.	compostos de pirazol e imidazol para inibição de il-17 e rorgama
EP3810141A1 (en)	2018-06-20	2021-04-28	Reata Pharmaceuticals, Inc.	Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
KR20210096162A (ko)	2018-11-27	2021-08-04	쿄와 기린 가부시키가이샤	의약 조성물
KR102891865B1 (ko)	2019-07-19	2025-11-26	리아타 파마슈티컬즈, 아이엔씨.	C17 극성-치환된 헤테로방향족 합성 트리터페노이드 및 그의 사용 방법
CN115803059A (zh)	2020-05-09	2023-03-14	里亚塔医药控股有限责任公司	使用甲基巴多索隆或其类似物治疗covid-19的方法
US12059419B2 (en)	2020-10-16	2024-08-13	Idience Co., Ltd.	Pharmaceutical composition comprising phthalazinone derivatives
WO2022126129A1 (en)	2020-12-11	2022-06-16	Reata Pharmaceuticals, Inc.	Synthetic triterpenoids for use in therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07121911B2 (ja) *	1986-03-26	1995-12-25	クミアイ化学工業株式会社	４（１ｈ）−ピリジノン誘導体および農園芸用殺菌剤
JPH01273020A (ja) *	1988-04-26	1989-10-31	Toray Ind Inc	有機非線形光学材料
US5064823A (en) *	1988-08-24	1991-11-12	Research Triangle Institute	Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
JP2876144B2 (ja) *	1990-03-23	1999-03-31	東洋フアルマー株式会社	３―フェニルクマリン―７―イルオキシ酢酸誘導体とその製法及び用途
GB9622173D0 (en) *	1996-10-24	1996-12-18	Glaxo Group Ltd	Particulate Products
US20050276836A1 (en) *	1997-06-11	2005-12-15	Michelle Wilson	Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
US6326507B1 (en)	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
US6890946B2 (en) *	1999-12-23	2005-05-10	Indiana University Research And Technology Corporation	Use of parthenolide to inhibit cancer
US7435755B2 (en) *	2000-11-28	2008-10-14	The Trustees Of Dartmouth College	CDDO-compounds and combination therapies thereof
WO2002047611A2 (en) *	2000-11-28	2002-06-20	Board Of Regents, The University Of Texas System	Cddo-compounds and combination therapies thereof
EP1507541A4 (en) *	2002-05-13	2009-06-03	Dartmouth College	HEMMER AND APPLICATION METHOD THEREFOR
JP3618341B2 (ja) *	2003-04-15	2005-02-09	山之内製薬株式会社	臭化物及びその結晶
FR2861299B1 (fr) *	2003-10-28	2006-01-27	Pf Medicament	Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
CN100419534C (zh)	2003-12-08	2008-09-17	索尼株式会社	液晶显示设备和背光调节方法
US20060167097A1 (en) *	2004-04-16	2006-07-27	Cheppail Ramachandran	Compositions and uses of Amooranin compounds
EP1904480A2 (en) *	2005-05-23	2008-04-02	Novartis Pharma AG	Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
DE102005041613A1 (de)	2005-09-01	2007-03-08	Ergonex Pharma Gmbh	Pharmazeutische Zusammensetzungen zur Behandlung von Karzinoid-Syndrom
US8067357B2 (en)	2005-12-12	2011-11-29	Mosamedix B.V.	Annexin derivatives suitable for pretargeting in therapy and diagnosis
US8088824B2 (en) *	2007-08-15	2012-01-03	Reata Pharmaceuticals Inc.	Forms of CDDO methyl ester

2008
- 2008-08-13 US US12/191,176 patent/US8088824B2/en active Active
- 2008-08-14 PT PT121536056T patent/PT2450057T/pt unknown
- 2008-08-14 MX MX2010001628A patent/MX2010001628A/es active IP Right Grant
- 2008-08-14 EP EP08795303A patent/EP2187741B1/en active Active
- 2008-08-14 KR KR1020107005094A patent/KR101481764B1/ko active Active
- 2008-08-14 CL CL2008002417A patent/CL2008002417A1/es unknown
- 2008-08-14 PL PL08795303T patent/PL2187741T3/pl unknown
- 2008-08-14 ES ES12153605.6T patent/ES2602978T3/es active Active
- 2008-08-14 DK DK12153605.6T patent/DK2450057T3/en active
- 2008-08-14 HR HRP20120350AT patent/HRP20120350T1/hr unknown
- 2008-08-14 CN CN2008801112346A patent/CN101820758B/zh active Active
- 2008-08-14 CA CA2871864A patent/CA2871864C/en active Active
- 2008-08-14 HU HUE12153605A patent/HUE031866T2/en unknown
- 2008-08-14 SI SI200830650T patent/SI2187741T1/sl unknown
- 2008-08-14 SG SG2011094158A patent/SG177905A1/en unknown
- 2008-08-14 WO PCT/US2008/009703 patent/WO2009023232A1/en not_active Ceased
- 2008-08-14 SI SI200831728A patent/SI2450057T1/sl unknown
- 2008-08-14 JP JP2010521031A patent/JP5005812B2/ja active Active
- 2008-08-14 PL PL12153605T patent/PL2450057T3/pl unknown
- 2008-08-14 EA EA201070149A patent/EA018704B1/ru unknown
- 2008-08-14 LT LTEP12153605.6T patent/LT2450057T/lt unknown
- 2008-08-14 AU AU2008287388A patent/AU2008287388B2/en active Active
- 2008-08-14 CA CA2696330A patent/CA2696330C/en active Active
- 2008-08-14 PT PT08795303T patent/PT2187741E/pt unknown
- 2008-08-14 SG SG10201504650VA patent/SG10201504650VA/en unknown
- 2008-08-14 TW TW102134576A patent/TWI486357B/zh active
- 2008-08-14 KR KR1020147002848A patent/KR101544766B1/ko active Active
- 2008-08-14 EP EP12153605.6A patent/EP2450057B1/en active Active
- 2008-08-14 NZ NZ583269A patent/NZ583269A/en unknown
- 2008-08-14 CN CN201310016448.8A patent/CN103254267B/zh active Active
- 2008-08-14 BR BRPI0815540A patent/BRPI0815540A8/pt not_active Application Discontinuation
- 2008-08-14 EA EA201370109A patent/EA023550B1/ru unknown
- 2008-08-14 DK DK08795303.0T patent/DK2187741T3/da active
- 2008-08-14 AT AT08795303T patent/ATE549035T1/de active
- 2008-08-14 TW TW097130947A patent/TWI419899B/zh active
- 2008-08-14 ES ES08795303T patent/ES2382571T3/es active Active
- 2008-08-14 AR ARP080103557A patent/AR073155A1/es unknown
2010
- 2010-02-09 IL IL203824A patent/IL203824A/en active IP Right Grant
- 2010-02-12 ZA ZA201001066A patent/ZA201001066B/xx unknown
2011
- 2011-11-29 US US13/306,043 patent/US8309601B2/en active Active
2012
- 2012-05-23 JP JP2012117773A patent/JP2012188438A/ja active Pending
- 2012-06-13 CY CY20121100542T patent/CY1112864T1/el unknown
- 2012-06-29 US US13/537,583 patent/US8633243B2/en active Active
2015
- 2015-05-07 JP JP2015094538A patent/JP2015164939A/ja active Pending
2016
- 2016-11-15 HR HRP20161503TT patent/HRP20161503T1/hr unknown
- 2016-11-23 CY CY20161101205T patent/CY1118329T1/el unknown
2017
- 2017-03-27 IL IL251419A patent/IL251419A0/en unknown
- 2017-08-10 JP JP2017154939A patent/JP2018009001A/ja active Pending
2020
- 2020-03-25 AR ARP200100825A patent/AR119704A2/es unknown

Also Published As

Publication number	Publication date
US8088824B2 (en)	2012-01-03
CY1118329T1 (el)	2017-06-28
CN101820758A (zh)	2010-09-01
PL2450057T3 (pl)	2017-02-28
US8633243B2 (en)	2014-01-21
ES2602978T3 (es)	2017-02-23
JP5005812B2 (ja)	2012-08-22
AU2008287388A1 (en)	2009-02-19
PT2187741E (pt)	2012-06-21
HRP20161503T1 (hr)	2017-01-13
TWI486357B (zh)	2015-06-01
HUE031866T2 (en)	2017-08-28
US20090048204A1 (en)	2009-02-19
KR101481764B1 (ko)	2015-01-13
TWI419899B (zh)	2013-12-21
WO2009023232A1 (en)	2009-02-19
PL2187741T3 (pl)	2012-08-31
CN101820758B (zh)	2013-03-06
ES2382571T3 (es)	2012-06-11
CA2696330C (en)	2015-03-24
CN103254267B (zh)	2016-03-16
EP2450057B1 (en)	2016-09-28
SG177905A1 (en)	2012-02-28
PT2450057T (pt)	2016-12-15
DK2450057T3 (en)	2016-12-19
KR20140024063A (ko)	2014-02-27
CL2008002417A1 (es)	2009-03-27
CA2871864C (en)	2016-05-17
TW201402597A (zh)	2014-01-16
EP2450057A1 (en)	2012-05-09
IL203824A (en)	2017-04-30
BRPI0815540A2 (pt)	2014-09-30
EP2187741A4 (en)	2010-08-25
JP2010536754A (ja)	2010-12-02
HRP20120350T1 (hr)	2012-05-31
EP2187741A1 (en)	2010-05-26
SI2187741T1 (sl)	2012-07-31
JP2012188438A (ja)	2012-10-04
BRPI0815540A8 (pt)	2023-04-11
JP2018009001A (ja)	2018-01-18
SG10201504650VA (en)	2015-07-30
JP2015164939A (ja)	2015-09-17
NZ583269A (en)	2012-03-30
CA2871864A1 (en)	2009-02-19
AR119704A2 (es)	2022-01-05
CN103254267A (zh)	2013-08-21
HK1143537A1 (en)	2011-01-07
ATE549035T1 (de)	2012-03-15
MX2010001628A (es)	2010-06-02
LT2450057T (lt)	2016-12-27
EA018704B1 (ru)	2013-10-30
IL251419A0 (en)	2017-05-29
EA023550B1 (ru)	2016-06-30
EA201070149A1 (ru)	2010-08-30
DK2187741T3 (da)	2012-04-16
EP2187741B1 (en)	2012-03-14
US20120071684A1 (en)	2012-03-22
US8309601B2 (en)	2012-11-13
AU2008287388B2 (en)	2014-11-06
TW200916476A (en)	2009-04-16
US20120330050A1 (en)	2012-12-27
CY1112864T1 (el)	2016-04-13
CA2696330A1 (en)	2009-02-19
KR101544766B1 (ko)	2015-08-17
AR073155A1 (es)	2010-10-20
EA201370109A1 (ru)	2014-01-30
SI2450057T1 (sl)	2017-01-31
KR20100056488A (ko)	2010-05-27

Publication	Publication Date	Title
ZA201001066B (en)	2010-10-27	Novel forms of CDDO methyl ester
PL3296284T3 (pl)	2022-06-13	Nieterapeutyczne zastosowanie estru hydroksymaślanowego
IL234285B (en)	2018-04-30	A process for the preparation of boronate ester compounds and their intermediates
EP2250185A4 (en)	2011-11-16	NEW LUPANDERIVATE
ZA201006252B (en)	2011-06-29	Preparation of lenalidomide
EP2282755A4 (en)	2015-06-17	INHIBITION OF ANGIOGENESIS
IL212119A0 (en)	2011-06-30	Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
EP2231687A4 (en)	2012-11-14	NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES
PL2133419T3 (pl)	2019-02-28	Zastosowania beta-dipeptydów cyjanoficyny
GB0810219D0 (en)	2008-07-09	Masonary bracket
IL211052A0 (en)	2011-04-28	Synthesis of glatiramer acetate
PL2171061T3 (pl)	2019-03-29	Preparat esterazy
ZA201006228B (en)	2011-11-30	Combined use of cholestanol derivative
PL2278890T3 (pl)	2015-05-29	Kompozycje fitosteroli o zwiększonej dostępności biologicznej
GB201114396D0 (en)	2011-10-05	Location of basesation
EP2331490A4 (en)	2012-09-26	PREPARATION OF DIBUTOXYMETHANE
IL206021A0 (en)	2010-11-30	Crystalline form of azelastine
GB2460350B (en)	2011-04-06	Intermediates for the preparation of bile acids
PL384673A1 (pl)	2009-09-14	Zestaw podokładzinowych listew dekoracyjnych
GB0809256D0 (en)	2008-06-25	Hollow wall fixing
PL386302A1 (pl)	2010-04-26	Nowa pochodna izotiazolopirydyny
GB0811883D0 (en)	2008-07-30	Preparation of glycoside esters
GB0708898D0 (en)	2007-06-20	Preparation of glycoside esters
GB0821710D0 (en)	2008-12-31	Derivatives of dihydroindolone
TWM311768U (en)	2007-05-11	Improved structure of A-ladder